FISH analysis - t(14;16) (IGH/MAF) 14q32 and 16q23 translocation and fusion
Definition
This translocation places the c-MAF oncogene at 16q23 under the control of the IGH enhancer, causing overexpression of c-MAF. It is seen in approximately 3 to 7% of newly diagnosed multiple myeloma patients. c-MAF overexpression has been associated with intrinsic resistance to proteasome inhibitors and is included as a poor prognostic factor in the revised staging system.
Method
FISH analysis
Accepted sample types
Peripheral blood, bone marrow (heparin), blood (heparin)
Description
Diagnosis and monitoring of MM.
Inheritance
Somatic; it arises in the malignant clone of plasma cell origin, and is not hereditary.